Ultragenyx Pharmaceutical
RARE
RARE
161 hedge funds and large institutions have $3.39B invested in Ultragenyx Pharmaceutical in 2015 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 89 increasing their positions, 30 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less call options, than puts
Call options by funds: $21.7M | Put options by funds: $35.6M
Holders
161
Holding in Top 10
2
Calls
$21.7M
Puts
$35.6M
Top Buyers
| 1 | +$70M | |
| 2 | +$40.4M | |
| 3 | +$36.5M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$34.1M |
| 5 |
Goldman Sachs
New York
|
+$33.1M |
Top Sellers
| 1 | -$104M | |
| 2 | -$47.8M | |
| 3 | -$22.2M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$21.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18M |